Chemotherapeutic Efficacy Enhancement in P-gp-Overexpressing Cancer Cells by Flavonoid-Loaded Polymeric Micelles

Multidrug resistance is the major problem in cancer treatment nowadays. Compounds from plants are the new targets to solve this problem. Quercetin (QCT), quercetrin (QTR), and rutin (RUT) are potential anticancer flavonoids but their poor water solubility leads to less efficacy. In this study, the polymeric micelles of benzoylated methoxy-poly (ethylene glycol)-b-oligo(ε-caprolactone) or mPEG-b-OCL-Bz loading with the flavonoids were prepared to solve these problems. The flavonoid-loaded micelles showed an average size of 13–20 nm and maximum loading capacity of 35% (w/w). The release of QCT (21%, 3 h) was lower than that of QTR (51%, 3 h) and RUT (58%, 3 h). QCT (free and micelle forms) exhibited significantly higher cytotoxicity against P-glycoprotein-overexpressing leukemia (K562/ADR) cells than QTR and RUT (p < 0.05). The results demonstrated that QCT-loaded micelles effectively reversed cytotoxicity of both doxorubicin (multidrug resistant reversing (δ) values up to 0.71) and daunorubicin (δ values up to 0.74) on K562/ADR cells. It was found that QCT-loaded micelles as well as empty polymeric micelles inhibited P-gp efflux of tetrahydropyranyl Adriamycin. Besides, mitochondrial membrane potential was decreased by QCT (in its free form and micellar formation). Our results suggested that the combination effects of polymeric micelles (inhibiting P-gp efflux) and QCT (interfering mitochondrial membrane potential) might be critical factors contributing to the reversing multidrug resistance of K562/ADR cells by QCT-loaded micelles. We concluded that QCT-loaded mPEG-b-OCL-Bz micelles are the attractive systems for overcoming multidrug-resistant cancer cells.

[1]  Y. Assaraf,et al.  The multi-factorial nature of clinical multidrug resistance in cancer. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[2]  Zehra Tavsan,et al.  Flavonoids showed anticancer effects on the ovarian cancer cells: Involvement of reactive oxygen species, apoptosis, cell cycle and invasion. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  S. Kothan,et al.  In vitro evaluation of P-glycoprotein functions in human neuroblastoma cell lines , 2019 .

[4]  O. Firuzi,et al.  5‐Oxo‐hexahydroquinoline derivatives as modulators of P‐gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells , 2019, Toxicology and applied pharmacology.

[5]  Q. Zong,et al.  Co-delivery of Metformin and Paclitaxel Via Folate-Modified pH-Sensitive Micelles for Enhanced Anti-tumor Efficacy , 2018, AAPS PharmSciTech.

[6]  Maria-José U. Ferreira,et al.  Monoterpene indole alkaloid azine derivatives as MDR reversal agents. , 2018, Bioorganic & medicinal chemistry.

[7]  P. Opanasopit,et al.  Development of Chitosan-Based pH-Sensitive Polymeric Micelles Containing Curcumin for Colon-Targeted Drug Delivery , 2017, AAPS PharmSciTech.

[8]  Yao Jin,et al.  Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles. , 2017, Acta biomaterialia.

[9]  Jiulong Zhang,et al.  Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance. , 2017, Acta biomaterialia.

[10]  I. Bechmann,et al.  Tumor tissue slice cultures as a platform for analyzing tissue‐penetration and biological activities of nanoparticles , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  L. Chow,et al.  Flavonoid dimers are highly potent killers of multidrug resistant cancer cells overexpressing MRP1 , 2017, Biochemical pharmacology.

[12]  Z. Gu,et al.  Terminal modification of polymeric micelles with π-conjugated moieties for efficient anticancer drug delivery. , 2015, Biomaterials.

[13]  V. Préat,et al.  Paclitaxel-loaded micelles enhance transvascular permeability and retention of nanomedicines in tumors. , 2015, International journal of pharmaceutics.

[14]  T. Efferth,et al.  Cytotoxicity and modes of action of 4'-hydroxy-2',6'-dimethoxychalcone and other flavonoids toward drug-sensitive and multidrug-resistant cancer cell lines. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[15]  K. Michalak,et al.  Polyphenols counteract tumor cell chemoresistance conferred by multidrug resistance proteins. , 2012, Anti-cancer agents in medicinal chemistry.

[16]  Sidhartha Hazari,et al.  Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. , 2012, The American journal of pathology.

[17]  W. Hennink,et al.  Cytostatic effect of xanthone-loaded mPEG-b-p(HPMAm-Lac2) micelles towards doxorubicin sensitive and resistant cancer cells. , 2012, Colloids and surfaces. B, Biointerfaces.

[18]  Ming-Fa Hsieh,et al.  Targeted delivery of doxorubicin to human breast cancers by folate-decorated star-shaped PEG–PCL micelle , 2012 .

[19]  M. Uesaka,et al.  Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. , 2011, Nature nanotechnology.

[20]  W. Hennink,et al.  PEG-OCL micelles for quercetin solubilization and inhibition of cancer cell growth. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[21]  Huibi Xu,et al.  Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles. , 2011, Biomaterials.

[22]  Dar-Ren Chen,et al.  Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells , 2010, Archives of pharmacal research.

[23]  F. Liu,et al.  Paclitaxel nanocrystals for overcoming multidrug resistance in cancer. , 2010, Molecular pharmaceutics.

[24]  N. Dechsupa,et al.  Quercetin, quercetrin except rutin potentially increased pirarubicin cytotoxicity by non-competitively inhibiting the P-glycoprotein-and MRP1 function in living K562/adr and GLC4/adr cells , 2010 .

[25]  H. Toyoda,et al.  Effects of Naturally Occurring Polymethyoxyflavonoids on Cell Growth, P-Glycoprotein Function, Cell Cycle, and Apoptosis of Daunorubicin-Resistant T Lymphoblastoid Leukemia Cells , 2010, Cancer investigation.

[26]  Hua Xiao,et al.  Carbon nanotubes as intracellular carriers for multidrug resistant cells studied by capillary electrophoresis-laser-induced fluorescence. , 2010, Methods in molecular biology.

[27]  G. P. Agrawal,et al.  Nanoparticles as novel carrier for brain delivery: a review. , 2009, Current pharmaceutical design.

[28]  Ming-Jium Shieh,et al.  Self-assembled star-shaped chlorin-core poly(epsilon-caprolactone)-poly(ethylene glycol) diblock copolymer micelles for dual chemo-photodynamic therapies. , 2008, Biomaterials.

[29]  C. van Nostrum,et al.  The effect of core composition in biodegradable oligomeric micelles as taxane formulations. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  M. Yokoyama,et al.  What are determining factors for stable drug incorporation into polymeric micelle carriers? Consideration on physical and chemical characters of the micelle inner core. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[31]  T. Efferth,et al.  Chemotherapy-induced resistance by ATP-binding cassette transporter genes. , 2007, Biochimica et biophysica acta.

[32]  W. Hennink,et al.  Small oligomeric micelles based on end group modified mPEG : Oligocaprolactone with monodisperse hydrophobic blocks , 2007 .

[33]  L. Goya,et al.  Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). , 2006, The Journal of nutrition.

[34]  M. Radosz,et al.  Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy. , 2006, Colloids and surfaces. B, Biointerfaces.

[35]  M. Hirai,et al.  Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells. , 2005, Biological & pharmaceutical bulletin.

[36]  S. Wolffram,et al.  Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT? , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[37]  Mustafa Usta,et al.  Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. , 2005, Biochemical pharmacology.

[38]  P. Limtrakul,et al.  Inhibition of P-Glycoprotein Function and Expression by Kaempferol and Quercetin , 2005, Journal of chemotherapy.

[39]  J. Sedlák,et al.  Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants. , 2005, Neoplasma.

[40]  T. Okano,et al.  Polymer Design and Incorporation Methods for Polymeric Micelle Carrier System Containing Water-insoluble Anti-cancer Agent Camptothecin , 2004, Journal of drug targeting.

[41]  Christine Allen,et al.  Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine. , 2004, Journal of pharmaceutical sciences.

[42]  M. Ponglikitmongkol,et al.  Functional study of intracellular P-gp- and MRP1-mediated pumping of free cytosolic pirarubicin into acidic organelles in intrinsic resistant SiHa cells. , 2003, Canadian journal of physiology and pharmacology.

[43]  Paiboon Reungpatthanaphong,et al.  Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines. , 2002, Biological & pharmaceutical bulletin.

[44]  J. Jay-Gerin,et al.  Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines. , 2002, Canadian journal of physiology and pharmacology.

[45]  Johnson Ww.  P-glycoprotein-mediated efflux as a major factor in the variance of absorption and distribution of drugs: modulation of chemotherapy resistance. , 2002 .

[46]  Vladimir P Torchilin,et al.  Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating. , 2002, International journal of pharmaceutics.

[47]  W. W. Johnson,et al.  P-glycoprotein-mediated efflux as a major factor in the variance of absorption and distribution of drugs: modulation of chemotherapy resistance. , 2002, Methods and findings in experimental and clinical pharmacology.

[48]  A. Kabanov,et al.  Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. , 2001, The Journal of pharmacology and experimental therapeutics.

[49]  A. Kabanov,et al.  Selective energy depletion and sensitization of multiple drug‐resistant cancer cells by pluronic block copolymer , 2000 .

[50]  E. Teodori,et al.  Study of P-glycoprotein functionality in living resistant K562 cells after photolabeling with a verapamil analogue. , 1996, Biochemical pharmacology.

[51]  P. Bernardi.  The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. , 1996, Biochimica et biophysica acta.

[52]  P. Petit,et al.  Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[53]  T. Tsuruo,et al.  Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody. , 1991, Journal of the National Cancer Institute.

[54]  J. Tennant.  EVALUATION OF THE TRYPAN BLUE TECHNIQUE FOR DETERMINATION OF CELL VIABILITY , 1964, Transplantation.